Hippotherapy to Improve the Balance of Children With Movement Disorders

NCT ID: NCT01313325

Last Updated: 2011-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-09-30

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if adding hippotherapy treatment will improve balance for children ages 5-17 who have disabilities such as cerebral palsy and down syndrome. We also want to find out if by improving their balance the children increase their participation in age appropriate activities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary purpose of this study is to determine the effects of hippotherapy on the balance of children with developmental disorders that cause mild to moderate balance problems. The secondary purpose is to determine if the use of hippotherapy also improves perceived functional abilities and thus quality of life as measured by the pediatric balance scale and Activities Scale for Kids (respectively)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Diseases Cerebral Palsy Down Syndrome Autism Developmental Coordination Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment group

Children between 5-17 years who have balance deficits related to any movement disorder (preferably neuromuscular)

Group Type EXPERIMENTAL

Hippotherapy

Intervention Type OTHER

Children will receive treatment by a licensed physical therapist using hippotherapy as the treatment strategy. This includes sitting on a horse who's movement is controlled by a horse leader, with the PT directing the movements required of the horse, as well as supplying supplemental cues to the participant. Alternative positions (such as sitting backward and sideways) may also be used during the treatment session.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hippotherapy

Children will receive treatment by a licensed physical therapist using hippotherapy as the treatment strategy. This includes sitting on a horse who's movement is controlled by a horse leader, with the PT directing the movements required of the horse, as well as supplying supplemental cues to the participant. Alternative positions (such as sitting backward and sideways) may also be used during the treatment session.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* between the ages of 5 and 17
* have a neuromuscular diagnosis or confirmed difficulties with balance
* be able to stand 4 seconds without an assistive device
* be able to follow testing instructions
* must be under 250 pounds
* be able to attend a minimum 10/12 sessions.

Exclusion Criteria

* any compounding orthopedic or medical condition not related to the primary developmental diagnosis.
* previous hippotherapy intervention or therapeutic riding experience
* allergies or aversion to horses.
* refusal of parents to sign the therapeutic riding center's liability release form
* any new treatments (includes therapies, drugs, or other complementary treatments) within one month of the start of the study or plans for new treatments during the intervention period
* lack of a physician referral for physical therapy
Minimum Eligible Age

5 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Michigan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Central Michigan University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Debbie J Silkwood-Sherer, PT, DHS

Role: PRINCIPAL_INVESTIGATOR

Central Michigan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHUM Therapeutic Riding Center

Dansville, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

McGibbon NH, Benda W, Duncan BR, Silkwood-Sherer D. Immediate and long-term effects of hippotherapy on symmetry of adductor muscle activity and functional ability in children with spastic cerebral palsy. Arch Phys Med Rehabil. 2009 Jun;90(6):966-74. doi: 10.1016/j.apmr.2009.01.011.

Reference Type BACKGROUND
PMID: 19480872 (View on PubMed)

Casady RL, Nichols-Larsen DS. The effect of hippotherapy on ten children with cerebral palsy. Pediatr Phys Ther. 2004 Fall;16(3):165-72. doi: 10.1097/01.PEP.0000136003.15233.0C.

Reference Type BACKGROUND
PMID: 17057544 (View on PubMed)

Benda W, McGibbon NH, Grant KL. Improvements in muscle symmetry in children with cerebral palsy after equine-assisted therapy (hippotherapy). J Altern Complement Med. 2003 Dec;9(6):817-25. doi: 10.1089/107555303771952163.

Reference Type BACKGROUND
PMID: 14736353 (View on PubMed)

Silkwood-Sherer D, Warmbier H. Effects of hippotherapy on postural stability, in persons with multiple sclerosis: a pilot study. J Neurol Phys Ther. 2007 Jun;31(2):77-84. doi: 10.1097/NPT.0b013e31806769f7.

Reference Type BACKGROUND
PMID: 17558361 (View on PubMed)

Silkwood-Sherer D. Hippotherapy as an Intervention to Improve Postural Control of Children with Movement Disorders. Dev Med Child Neurol 51(S5):18-19, 2009 [abstract]

Reference Type RESULT

Silkwood-Sherer DJ, Killian CB, Long TM, Martin KS. Hippotherapy--an intervention to habilitate balance deficits in children with movement disorders: a clinical trial. Phys Ther. 2012 May;92(5):707-17. doi: 10.2522/ptj.20110081. Epub 2012 Jan 12.

Reference Type DERIVED
PMID: 22247403 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.americanhippotherapyassociation.org

Non profit organization that provides education, standards, terminology for physical, occupational and speech language pathologists using hippotherapy as part of their practice.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

09/14/2006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.